The FDA vs. Commercial Speech
How restricting the promotion of "off-label" pharmaceutical use puts doctors and patients at risk
How restricting the promotion of "off-label" pharmaceutical use puts doctors and patients at risk
The Supreme Court prepares to hear a major Fifth Amendment case.
New from Reason: a look into what Javier Milei has accomplished and what it will take to make the most of Argentina’s window for real change. Out now for subscribers.